advertisement

Topcon

Vajaranant TS 1

Showing records 1 to 1 | Display all abstracts from Vajaranant TS

92541 Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucoma
Mehta AA; Kanu LN; Sood-Mendiratta S; Quinones R; Hawkins A; Lehrer RA; Malhotra K; Papas R; Hillman D; Wilensky JT; Aref AA; Vajaranant TS; Edward DP
European Journal of Ophthalmology 2021; 0: 1120672121998913

Issue 22-1

Change Issue


advertisement

Oculus